Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis. View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-04-06

AUTHORS

J -Y Reginster, F Bianic, R Campbell, M Martin, S A Williams, L A Fitzpatrick

ABSTRACT

This network meta-analysis assessed the efficacy of abaloparatide versus other treatment options to reduce the risk of fractures in women with postmenopausal osteoporosis. The analysis indicates that abaloparatide reduces the risk of fractures in women with postmenopausal osteoporosis versus placebo and compared with other treatment options. INTRODUCTION: This network meta-analysis (NMA) assessed the relative efficacy of abaloparatide versus other treatments to reduce the risk of fractures in women with postmenopausal osteoporosis (PMO). METHODS: PubMed®, Embase®, and the Cochrane Central Register of Controlled Trials were searched for randomized controlled trials published before December 20, 2017, that included women with PMO who were eligible to receive interventions for primary or secondary fracture prevention. The NMA was conducted by fracture site (vertebral [VF], nonvertebral [NVF], and wrist), with the relative risk (RR) of fracture versus placebo the main clinical endpoint. The NMA used fixed-effects and random-effects approaches. RESULTS: A total of 4978 articles were screened, of which 22 were included in the analysis. Compared with other treatments, abaloparatide demonstrated the greatest treatment effect relative to placebo in the VF network (RR = 0.13; 95% credible interval [CrI] 0.04-0.34), the NVF network (RR = 0.50; 95% CrI 0.28-0.85), and the wrist fracture network (RR = 0.39; CrI 0.15-0.90). Treatment ranking showed that abaloparatide had the highest estimated probability of preventing fractures in each of the networks (79% for VF, 70% for NVF, and 53% for wrist fracture) compared with other treatments. Individual networks demonstrated a good level of agreement with direct trial evidence and direct pair-wise comparisons. CONCLUSIONS: This NMA indicates that abaloparatide reduces the RR of VF, NVF, and wrist fracture in women with PMO with or without prior fracture versus placebo, compared with other treatment options. Limitations include that adverse events and drug costs were not considered, and that generalizability is limited to the trial populations and endpoints included in the NMA. More... »

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00198-019-04947-2

DOI

http://dx.doi.org/10.1007/s00198-019-04947-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1113261708

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30953114


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "University of Li\u00e8ge", 
          "id": "https://www.grid.ac/institutes/grid.4861.b", 
          "name": [
            "Universit\u00e9 de Li\u00e8ge, Place du 20 Ao\u00fbt 7, 4000, Li\u00e8ge, Belgium. jyreginster@ulg.ac.be."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Reginster", 
        "givenName": "J -Y", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Syneos Health, London, UK."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Bianic", 
        "givenName": "F", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Syneos Health, London, UK."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Campbell", 
        "givenName": "R", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Syneos Health, London, UK."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Martin", 
        "givenName": "M", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radius Health (United States)", 
          "id": "https://www.grid.ac/institutes/grid.488375.5", 
          "name": [
            "Radius Health, Inc., Waltham, MA, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Williams", 
        "givenName": "S A", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Radius Health (United States)", 
          "id": "https://www.grid.ac/institutes/grid.488375.5", 
          "name": [
            "Radius Health, Inc., Waltham, MA, USA."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fitzpatrick", 
        "givenName": "L A", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1359/jbmr.061113", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000304064"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/en.2015-1726", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000474083"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-016-3888-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1000948766", 
          "https://doi.org/10.1007/s00198-016-3888-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s13643-015-0133-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014050637", 
          "https://doi.org/10.1186/s13643-015-0133-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-015-3046-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015995190", 
          "https://doi.org/10.1007/s00198-015-3046-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0272989x14545789", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017569395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/0272989x14545789", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017569395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(15)61120-5", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017732303"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2016.11136", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021041547"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-006-0172-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025193568", 
          "https://doi.org/10.1007/s00198-006-0172-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-006-0172-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025193568", 
          "https://doi.org/10.1007/s00198-006-0172-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/gme.0000000000000466", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026575752"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/gme.0000000000000466", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026575752"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-012-2068-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030260530", 
          "https://doi.org/10.1007/s00198-012-2068-9"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa022436", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033420803"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0197-2456(86)90046-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034546744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0197-2456(86)90046-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034546744"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199511303332201", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035503090"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1532-5415.2003.51110.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036024255"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-015-3253-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039093283", 
          "https://doi.org/10.1007/s00198-015-3253-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-015-3253-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039093283", 
          "https://doi.org/10.1007/s00198-015-3253-4"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bone.2006.11.001", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043557835"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000453138", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044722017"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00198-012-2074-y", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046005055", 
          "https://doi.org/10.1007/s00198-012-2074-y"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa050336", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050100525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1017/s0266462312000086", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1054887876"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1759720x09339551", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064077424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1759720x09339551", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064077424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2004-1774", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064288066"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2011-3060", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064293280"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.85.5.1895", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064301395"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.85.6.2129", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064301424"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/22.4.719", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1075910802"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bone.2017.03.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084062711"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1708322", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091556708"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2018-00163", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104220399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2018-00163", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104220399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2018-00163", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104220399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2018-00163", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1104220399"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-04-06", 
    "datePublishedReg": "2019-04-06", 
    "description": "This network meta-analysis assessed the efficacy of abaloparatide versus other treatment options to reduce the risk of fractures in women with postmenopausal osteoporosis. The analysis indicates that abaloparatide reduces the risk of fractures in women with postmenopausal osteoporosis versus placebo and compared with other treatment options.\nINTRODUCTION: This network meta-analysis (NMA) assessed the relative efficacy of abaloparatide versus other treatments to reduce the risk of fractures in women with postmenopausal osteoporosis (PMO).\nMETHODS: PubMed\u00ae, Embase\u00ae, and the Cochrane Central Register of Controlled Trials were searched for randomized controlled trials published before December 20, 2017, that included women with PMO who were eligible to receive interventions for primary or secondary fracture prevention. The NMA was conducted by fracture site (vertebral [VF], nonvertebral [NVF], and wrist), with the relative risk (RR) of fracture versus placebo the main clinical endpoint. The NMA used fixed-effects and random-effects approaches.\nRESULTS: A total of 4978 articles were screened, of which 22 were included in the analysis. Compared with other treatments, abaloparatide demonstrated the greatest treatment effect relative to placebo in the VF network (RR\u2009=\u20090.13; 95% credible interval [CrI] 0.04-0.34), the NVF network (RR\u2009=\u20090.50; 95% CrI 0.28-0.85), and the wrist fracture network (RR\u2009=\u20090.39; CrI 0.15-0.90). Treatment ranking showed that abaloparatide had the highest estimated probability of preventing fractures in each of the networks (79% for VF, 70% for NVF, and 53% for wrist fracture) compared with other treatments. Individual networks demonstrated a good level of agreement with direct trial evidence and direct pair-wise comparisons.\nCONCLUSIONS: This NMA indicates that abaloparatide reduces the RR of VF, NVF, and wrist fracture in women with PMO with or without prior fracture versus placebo, compared with other treatment options. Limitations include that adverse events and drug costs were not considered, and that generalizability is limited to the trial populations and endpoints included in the NMA.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00198-019-04947-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100834", 
        "issn": [
          "0937-941X", 
          "1433-2965"
        ], 
        "name": "Osteoporosis International", 
        "type": "Periodical"
      }
    ], 
    "name": "Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis.", 
    "productId": [
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30953114"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9100105"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00198-019-04947-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1113261708"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00198-019-04947-2", 
      "https://app.dimensions.ai/details/publication/pub.1113261708"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T14:18", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000372_0000000372/records_117100_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00198-019-04947-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00198-019-04947-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00198-019-04947-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00198-019-04947-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00198-019-04947-2'


 

This table displays all metadata directly associated to this object as RDF triples.

193 TRIPLES      20 PREDICATES      54 URIs      16 LITERALS      6 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00198-019-04947-2 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 schema:author N96ec16e6547c4cc3b14a084a61eb6827
4 schema:citation sg:pub.10.1007/s00198-006-0172-4
5 sg:pub.10.1007/s00198-012-2068-9
6 sg:pub.10.1007/s00198-012-2074-y
7 sg:pub.10.1007/s00198-015-3046-9
8 sg:pub.10.1007/s00198-015-3253-4
9 sg:pub.10.1007/s00198-016-3888-9
10 sg:pub.10.1186/s13643-015-0133-0
11 https://doi.org/10.1001/jama.2016.11136
12 https://doi.org/10.1016/0197-2456(86)90046-2
13 https://doi.org/10.1016/j.bone.2006.11.001
14 https://doi.org/10.1016/j.bone.2017.03.006
15 https://doi.org/10.1016/s0140-6736(15)61120-5
16 https://doi.org/10.1017/s0266462312000086
17 https://doi.org/10.1046/j.1532-5415.2003.51110.x
18 https://doi.org/10.1056/nejm199511303332201
19 https://doi.org/10.1056/nejmoa022436
20 https://doi.org/10.1056/nejmoa050336
21 https://doi.org/10.1056/nejmoa1708322
22 https://doi.org/10.1093/jnci/22.4.719
23 https://doi.org/10.1097/gme.0000000000000466
24 https://doi.org/10.1159/000453138
25 https://doi.org/10.1177/0272989x14545789
26 https://doi.org/10.1177/1759720x09339551
27 https://doi.org/10.1210/en.2015-1726
28 https://doi.org/10.1210/jc.2004-1774
29 https://doi.org/10.1210/jc.2011-3060
30 https://doi.org/10.1210/jc.2018-00163
31 https://doi.org/10.1210/jc.85.5.1895
32 https://doi.org/10.1210/jc.85.6.2129
33 https://doi.org/10.1359/jbmr.061113
34 schema:datePublished 2019-04-06
35 schema:datePublishedReg 2019-04-06
36 schema:description This network meta-analysis assessed the efficacy of abaloparatide versus other treatment options to reduce the risk of fractures in women with postmenopausal osteoporosis. The analysis indicates that abaloparatide reduces the risk of fractures in women with postmenopausal osteoporosis versus placebo and compared with other treatment options. INTRODUCTION: This network meta-analysis (NMA) assessed the relative efficacy of abaloparatide versus other treatments to reduce the risk of fractures in women with postmenopausal osteoporosis (PMO). METHODS: PubMed®, Embase®, and the Cochrane Central Register of Controlled Trials were searched for randomized controlled trials published before December 20, 2017, that included women with PMO who were eligible to receive interventions for primary or secondary fracture prevention. The NMA was conducted by fracture site (vertebral [VF], nonvertebral [NVF], and wrist), with the relative risk (RR) of fracture versus placebo the main clinical endpoint. The NMA used fixed-effects and random-effects approaches. RESULTS: A total of 4978 articles were screened, of which 22 were included in the analysis. Compared with other treatments, abaloparatide demonstrated the greatest treatment effect relative to placebo in the VF network (RR = 0.13; 95% credible interval [CrI] 0.04-0.34), the NVF network (RR = 0.50; 95% CrI 0.28-0.85), and the wrist fracture network (RR = 0.39; CrI 0.15-0.90). Treatment ranking showed that abaloparatide had the highest estimated probability of preventing fractures in each of the networks (79% for VF, 70% for NVF, and 53% for wrist fracture) compared with other treatments. Individual networks demonstrated a good level of agreement with direct trial evidence and direct pair-wise comparisons. CONCLUSIONS: This NMA indicates that abaloparatide reduces the RR of VF, NVF, and wrist fracture in women with PMO with or without prior fracture versus placebo, compared with other treatment options. Limitations include that adverse events and drug costs were not considered, and that generalizability is limited to the trial populations and endpoints included in the NMA.
37 schema:genre research_article
38 schema:inLanguage en
39 schema:isAccessibleForFree false
40 schema:isPartOf sg:journal.1100834
41 schema:name Abaloparatide for risk reduction of nonvertebral and vertebral fractures in postmenopausal women with osteoporosis: a network meta-analysis.
42 schema:productId N35cad29781f54f6ca9f3c8eba09096e6
43 Na6c1437a2a2244e0a05ad50403ad5fdc
44 Nad9865a1afda4e899f6124be0dd45f01
45 Ncc96569059ff499faae8793ad0fdf2a5
46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1113261708
47 https://doi.org/10.1007/s00198-019-04947-2
48 schema:sdDatePublished 2019-04-11T14:18
49 schema:sdLicense https://scigraph.springernature.com/explorer/license/
50 schema:sdPublisher N2e18f5c912ac4d8eb708251cba0bb6d1
51 schema:url http://link.springer.com/10.1007/s00198-019-04947-2
52 sgo:license sg:explorer/license/
53 sgo:sdDataset articles
54 rdf:type schema:ScholarlyArticle
55 N07abcd9283014d69989a70c8cb291c78 schema:name Syneos Health, London, UK.
56 rdf:type schema:Organization
57 N0b5d3270d3c241019cd3075167ed0d3b rdf:first N2f04bad0d8a94912b358b7fdb125e42f
58 rdf:rest rdf:nil
59 N19ee2f7c6e2b42b69f9403942128520f schema:affiliation https://www.grid.ac/institutes/grid.488375.5
60 schema:familyName Williams
61 schema:givenName S A
62 rdf:type schema:Person
63 N281577843e1c49e0811857aa363c09a5 schema:name Syneos Health, London, UK.
64 rdf:type schema:Organization
65 N2e18f5c912ac4d8eb708251cba0bb6d1 schema:name Springer Nature - SN SciGraph project
66 rdf:type schema:Organization
67 N2f04bad0d8a94912b358b7fdb125e42f schema:affiliation https://www.grid.ac/institutes/grid.488375.5
68 schema:familyName Fitzpatrick
69 schema:givenName L A
70 rdf:type schema:Person
71 N35cad29781f54f6ca9f3c8eba09096e6 schema:name nlm_unique_id
72 schema:value 9100105
73 rdf:type schema:PropertyValue
74 N52f06f110a914769891002f1bbd1502a schema:affiliation Nbbecd3b0fccb421fb1b317d9f3fd3fae
75 schema:familyName Bianic
76 schema:givenName F
77 rdf:type schema:Person
78 N5403dde858594878865c561cfac79ba2 rdf:first N704d68a2876c4675b55bea7cf2a4814a
79 rdf:rest Nfa9adc64e0fc4fce80fb1b1d071da5fc
80 N58943eb98464477f858fa45604c6123a rdf:first N52f06f110a914769891002f1bbd1502a
81 rdf:rest Ncf5d2cf8c29b45c19a8ccd42a04cacdf
82 N6f6da4fb1401463186d9329b297c43d4 schema:affiliation https://www.grid.ac/institutes/grid.4861.b
83 schema:familyName Reginster
84 schema:givenName J -Y
85 rdf:type schema:Person
86 N704d68a2876c4675b55bea7cf2a4814a schema:affiliation N07abcd9283014d69989a70c8cb291c78
87 schema:familyName Martin
88 schema:givenName M
89 rdf:type schema:Person
90 N96ec16e6547c4cc3b14a084a61eb6827 rdf:first N6f6da4fb1401463186d9329b297c43d4
91 rdf:rest N58943eb98464477f858fa45604c6123a
92 Na6c1437a2a2244e0a05ad50403ad5fdc schema:name doi
93 schema:value 10.1007/s00198-019-04947-2
94 rdf:type schema:PropertyValue
95 Nad9865a1afda4e899f6124be0dd45f01 schema:name dimensions_id
96 schema:value pub.1113261708
97 rdf:type schema:PropertyValue
98 Nbbecd3b0fccb421fb1b317d9f3fd3fae schema:name Syneos Health, London, UK.
99 rdf:type schema:Organization
100 Nbe0bc47260a84a26bf8ab9ecd58737b7 schema:affiliation N281577843e1c49e0811857aa363c09a5
101 schema:familyName Campbell
102 schema:givenName R
103 rdf:type schema:Person
104 Ncc96569059ff499faae8793ad0fdf2a5 schema:name pubmed_id
105 schema:value 30953114
106 rdf:type schema:PropertyValue
107 Ncf5d2cf8c29b45c19a8ccd42a04cacdf rdf:first Nbe0bc47260a84a26bf8ab9ecd58737b7
108 rdf:rest N5403dde858594878865c561cfac79ba2
109 Nfa9adc64e0fc4fce80fb1b1d071da5fc rdf:first N19ee2f7c6e2b42b69f9403942128520f
110 rdf:rest N0b5d3270d3c241019cd3075167ed0d3b
111 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
112 schema:name Medical and Health Sciences
113 rdf:type schema:DefinedTerm
114 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
115 schema:name Clinical Sciences
116 rdf:type schema:DefinedTerm
117 sg:journal.1100834 schema:issn 0937-941X
118 1433-2965
119 schema:name Osteoporosis International
120 rdf:type schema:Periodical
121 sg:pub.10.1007/s00198-006-0172-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025193568
122 https://doi.org/10.1007/s00198-006-0172-4
123 rdf:type schema:CreativeWork
124 sg:pub.10.1007/s00198-012-2068-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030260530
125 https://doi.org/10.1007/s00198-012-2068-9
126 rdf:type schema:CreativeWork
127 sg:pub.10.1007/s00198-012-2074-y schema:sameAs https://app.dimensions.ai/details/publication/pub.1046005055
128 https://doi.org/10.1007/s00198-012-2074-y
129 rdf:type schema:CreativeWork
130 sg:pub.10.1007/s00198-015-3046-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015995190
131 https://doi.org/10.1007/s00198-015-3046-9
132 rdf:type schema:CreativeWork
133 sg:pub.10.1007/s00198-015-3253-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039093283
134 https://doi.org/10.1007/s00198-015-3253-4
135 rdf:type schema:CreativeWork
136 sg:pub.10.1007/s00198-016-3888-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000948766
137 https://doi.org/10.1007/s00198-016-3888-9
138 rdf:type schema:CreativeWork
139 sg:pub.10.1186/s13643-015-0133-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014050637
140 https://doi.org/10.1186/s13643-015-0133-0
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1001/jama.2016.11136 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021041547
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1016/0197-2456(86)90046-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034546744
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1016/j.bone.2006.11.001 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043557835
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1016/j.bone.2017.03.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084062711
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1016/s0140-6736(15)61120-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017732303
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1017/s0266462312000086 schema:sameAs https://app.dimensions.ai/details/publication/pub.1054887876
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1046/j.1532-5415.2003.51110.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1036024255
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1056/nejm199511303332201 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035503090
157 rdf:type schema:CreativeWork
158 https://doi.org/10.1056/nejmoa022436 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033420803
159 rdf:type schema:CreativeWork
160 https://doi.org/10.1056/nejmoa050336 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050100525
161 rdf:type schema:CreativeWork
162 https://doi.org/10.1056/nejmoa1708322 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091556708
163 rdf:type schema:CreativeWork
164 https://doi.org/10.1093/jnci/22.4.719 schema:sameAs https://app.dimensions.ai/details/publication/pub.1075910802
165 rdf:type schema:CreativeWork
166 https://doi.org/10.1097/gme.0000000000000466 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026575752
167 rdf:type schema:CreativeWork
168 https://doi.org/10.1159/000453138 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044722017
169 rdf:type schema:CreativeWork
170 https://doi.org/10.1177/0272989x14545789 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017569395
171 rdf:type schema:CreativeWork
172 https://doi.org/10.1177/1759720x09339551 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064077424
173 rdf:type schema:CreativeWork
174 https://doi.org/10.1210/en.2015-1726 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000474083
175 rdf:type schema:CreativeWork
176 https://doi.org/10.1210/jc.2004-1774 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064288066
177 rdf:type schema:CreativeWork
178 https://doi.org/10.1210/jc.2011-3060 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064293280
179 rdf:type schema:CreativeWork
180 https://doi.org/10.1210/jc.2018-00163 schema:sameAs https://app.dimensions.ai/details/publication/pub.1104220399
181 rdf:type schema:CreativeWork
182 https://doi.org/10.1210/jc.85.5.1895 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064301395
183 rdf:type schema:CreativeWork
184 https://doi.org/10.1210/jc.85.6.2129 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064301424
185 rdf:type schema:CreativeWork
186 https://doi.org/10.1359/jbmr.061113 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000304064
187 rdf:type schema:CreativeWork
188 https://www.grid.ac/institutes/grid.4861.b schema:alternateName University of Liège
189 schema:name Université de Liège, Place du 20 Août 7, 4000, Liège, Belgium. jyreginster@ulg.ac.be.
190 rdf:type schema:Organization
191 https://www.grid.ac/institutes/grid.488375.5 schema:alternateName Radius Health (United States)
192 schema:name Radius Health, Inc., Waltham, MA, USA.
193 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...